Abstract
The need for right ventricular outflow tract reconstruction is common and growing in congenital heart surgery given expanding indications for the repair of congenital as well as acquired heart disease. Various valved conduit options currently exist including homografts, xenograft pulmonary valved conduits (Contegra™), and porcine valved conduits. The major limitation for all conduits is implant durability, which requires reoperation. Currently, cryopreserved homografts are often used given their superiority shown in long-term data. Significant limitations remain in the cost and availability of the graft, particularly for smaller sizes. Contegra conduits are available in a variety of sizes. Nonetheless, the data regarding long-term durability are less robust and studies comparing durability with homografts have been conflicting. Additionally, there is concern for increased rates of late endocarditis in this conduit. Porcine valved conduits offer a reliable option but are limited by structural valve degeneration associated with all types of bioprosthetic heart valve replacements. New developments in the field of tissue engineering have produced promising bio-restorative valved conduits that may overcome many of the limitations of previous conduit technologies. These remain in the early stages of clinical testing. This review summarizes the clinical data surrounding the conduits used most commonly in clinical practice today and explores emerging technologies that may bring us closer to developing the ideal conduit.
Similar content being viewed by others
References
Gilboa SM, Devine OJ, Kucik JE et al (2016) Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation 134(2):101–109. https://doi.org/10.1161/CIRCULATIONAHA.115.019307
Ross DN, Somerville J (1966) Correction of pulmonary atresia with a homograft aortic valve. Lancet 2(7479):1446–1447. https://doi.org/10.1016/s0140-6736(66)90600-3
Behrendt DM, Kirsh MM, Stern A, Sigmann J, Perry B, Sloan H (1974) The surgical therapy for pulmonary artery–right ventricular discontinuity. Ann Thorac Surg 18(2):122–137. https://doi.org/10.1016/s0003-4975(10)64337-8
Huyan Y, Chang Y, Song J (2021) Application of homograft valved conduit in cardiac surgery. Front Cardiovasc Med 8:7408710. https://doi.org/10.3389/fcvm.2021.740871
Xue Y, Kossar AP, Abramov A et al (2022) Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes. Cardiovasc Res. https://doi.org/10.1093/cvr/cvac002
Saleeb SF, Newburger JW, Geva T et al (2014) Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation 130(1):51–60. https://doi.org/10.1161/CIRCULATIONAHA.114.009835
Nomoto R, Sleeper LA, Borisuk MJ et al (2016) Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg 152(5):1333-1342 e3. https://doi.org/10.1016/j.jtcvs.2016.06.064
Daly RC, Orszulak TA, Schaff HV, McGovern E, Wallace RB (1991) Long-term results of aortic valve replacement with nonviable homografts. Circulation 84(5 Suppl):III81–III88
Clarke DR, Campbell DN, Hayward AR, Bishop DA (1993) Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 105(5):934–941 (Discussion 941-942)
Legare JF, Lee TD, Ross DB (2000) Cryopreservation of rat aortic valves results in increased structural failure. Circulation 102(19 Suppl 3):III75–III78. https://doi.org/10.1161/01.cir.102.suppl_3.iii-75
O’Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC (1987) A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 94(6):812–823
Steffen V, Marsch G, Burgwitz K, Kuehn C, Teebken OE (2016) Resistance to infection of long-term cryopreserved human aortic valve allografts. J Thorac Cardiovasc Surg 151(5):1251–1259. https://doi.org/10.1016/j.jtcvs.2015.11.029
Sharma A, Cote AT, Hosking MCK, Harris KC (2017) A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types. JACC Cardiovasc Interv 10(14):1449–1458. https://doi.org/10.1016/j.jcin.2017.04.025
Lewis MJ, Malm T, Hallbergson A et al (2022) Long-term follow-up of right ventricle to pulmonary artery biologic valved conduits used in pediatric congenital heart surgery. Pediatr Cardiol. https://doi.org/10.1007/s00246-022-02956-3
Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Darragh RK (2006) Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft. Ann Thorac Surg 82(3):909–916. https://doi.org/10.1016/j.athoracsur.2006.03.008
Askovich B, Hawkins JA, Sower CT et al (2007) Right ventricle-to-pulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg 84(3):907–911. https://doi.org/10.1016/j.athoracsur.2007.04.104. (Discussion 911-912)
Sinzobahamvya N, Wetter J, Blaschczok HC, Cho MY, Brecher AM, Urban AE (2001) The fate of small-diameter homografts in the pulmonary position. Ann Thorac Surg 72(6):2070–2076. https://doi.org/10.1016/s0003-4975(01)03178-2
Perron J, Moran AM, Gauvreau K, del Nido PJ, Mayer JE Jr, Jonas RA (1999) Valved homograft conduit repair of the right heart in early infancy. Ann Thorac Surg 68(2):542–548. https://doi.org/10.1016/s0003-4975(99)00614-1
Urban AE, Sinzobahamvya N, Brecher AM, Wetter J, Malorny S (1998) Truncus arteriosus: ten-year experience with homograft repair in neonates and infants. Ann Thorac Surg 66(6 Suppl):S183–S188. https://doi.org/10.1016/s0003-4975(98)01103-5
Hawkins JA, Bailey WW, Dillon T, Schwartz DC (1992) Midterm results with cryopreserved allograft valved conduits from the right ventricle to the pulmonary arteries. J Thorac Cardiovasc Surg 104(4):910–916
McGrath LB, Gonzalez-Lavin L, Graf D (1988) Pulmonary homograft implantation for ventricular outflow tract reconstruction: early phase results. Ann Thorac Surg 45(3):273–277. https://doi.org/10.1016/s0003-4975(10)62461-7
Gerestein CG, Takkenberg JJ, Oei FB et al (2001) Right ventricular outflow tract reconstruction with an allograft conduit. Ann Thorac Surg 71(3):911–917. https://doi.org/10.1016/s0003-4975(00)02440-1. (Discussion 917-918)
Bielefeld MR, Bishop DA, Campbell DN, Mitchell MB, Grover FL, Clarke DR (2001) Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg 71(2):482–487. https://doi.org/10.1016/s0003-4975(00)02521-2. (Discussion 487-488)
Junnil P, Cheanvechai C, Namchaisiri J et al (2021) Long-term course after pediatric right ventricular outflow tract reconstruction. Asian Cardiovasc Thorac Ann 29(6):483–489. https://doi.org/10.1177/0218492320983449
Meyns B, Jashari R, Gewillig M et al (2005) Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur J Cardiothorac Surg 28(2):211–216. https://doi.org/10.1016/j.ejcts.2005.03.041. (Discussion 216)
Dearani JA, Danielson GK, Puga FJ et al (2003) Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 75(2):399–410. https://doi.org/10.1016/s0003-4975(02)04547-2. (Discussion 410-411)
Mery CM, Guzman-Pruneda FA, De Leon LE et al (2016) Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J Thorac Cardiovasc Surg 151(2):432–439. https://doi.org/10.1016/j.jtcvs.2015.10.069
Herrmann JL, Larson EE, Mastropietro CW et al (2020) Right ventricular outflow tract reconstruction in infant truncus arteriosus: a 37-year experience. Ann Thorac Surg 110(2):630–637. https://doi.org/10.1016/j.athoracsur.2019.11.023
Saxena A, Salve GG, Betts K et al (2021) Outcomes following heterotopic placement of right ventricle to pulmonary artery conduits. World J Pediatr Congenit Heart Surg 12(2):220–229. https://doi.org/10.1177/2150135120975769
Selamet Tierney ES, Gersony WM, Altmann K et al (2005) Pulmonary position cryopreserved homografts: durability in pediatric Ross and non-Ross patients. J Thorac Cardiovasc Surg 130(2):282–286. https://doi.org/10.1016/j.jtcvs.2005.04.003
Wells WJ, Arroyo H Jr, Bremner RM, Wood J, Starnes VA (2002) Homograft conduit failure in infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg 124(1):88–96. https://doi.org/10.1067/mtc.2002.121158
Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A (2004) Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 127(1):242–250. https://doi.org/10.1016/j.jtcvs.2003.07.047
Sierra J, Christenson JT, Lahlaidi NH, Beghetti M, Kalangos A (2007) Right ventricular outflow tract reconstruction: what conduit to use? Homograft or Contegra? Ann Thorac Surg 84(2):606–610. https://doi.org/10.1016/j.athoracsur.2007.03.055. (Discussion 610-611)
Boethig D, Horke A, Hazekamp M et al (2019) A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry datadagger. Eur J Cardiothorac Surg 56(3):503–509. https://doi.org/10.1093/ejcts/ezz054
Bibevski S, Ruzmetov M, Fortuna RS, Turrentine MW, Brown JW, Ohye RG (2017) Performance of SynerGraft decellularized pulmonary allografts compared with standard cryopreserved allografts: results from multiinstitutional data. Ann Thorac Surg 103(3):869–874. https://doi.org/10.1016/j.athoracsur.2016.07.068
Ruzmetov M, Shah JJ, Geiss DM, Fortuna RS (2012) Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg 143(3):543–549. https://doi.org/10.1016/j.jtcvs.2011.12.032
Chauvette V, Bouhout I, Tarabzoni M et al (2022) Pulmonary homograft dysfunction after the Ross procedure using decellularized homografts—a multicenter study. J Thorac Cardiovasc Surg 163(4):1296-1305 e3. https://doi.org/10.1016/j.jtcvs.2020.06.139
Protopapas AD, Athanasiou T (2008) Contegra conduit for reconstruction of the right ventricular outflow tract: a review of published early and mid-time results. J Cardiothorac Surg 3:62. https://doi.org/10.1186/1749-8090-3-62
Falchetti A, Demanet H, Dessy H, Melot C, Pierrakos C, Wauthy P (2019) Contegra versus pulmonary homograft for right ventricular outflow tract reconstruction in newborns. Cardiol Young 29(4):505–510. https://doi.org/10.1017/S1047951119000143
Peivandi AD, Seiler M, Mueller KM et al (2019) Elastica degeneration and intimal hyperplasia lead to Contegra(R) conduit failure. Eur J Cardiothorac Surg 56(6):1154–1161. https://doi.org/10.1093/ejcts/ezz199
Shebani SO, McGuirk S, Baghai M et al (2006) Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg 29(3):397–405. https://doi.org/10.1016/j.ejcts.2005.11.040
Boethig D, Thies WR, Hecker H, Breymann T (2005) Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg 27(1):58–66. https://doi.org/10.1016/j.ejcts.2004.09.009
Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP (2005) Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg 79(2):625–631. https://doi.org/10.1016/j.athoracsur.2004.07.085
Kadner A, Dave H, Stallmach T, Turina M, Pretre R (2004) Formation of a stenotic fibrotic membrane at the distal anastomosis of bovine jugular vein grafts (Contegra) after right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 127(1):285–286. https://doi.org/10.1016/j.jtcvs.2003.08.031
Urso S, Rega F, Meuris B et al (2011) The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement. Eur J Cardiothorac Surg 40(3):603–609. https://doi.org/10.1016/j.ejcts.2010.11.081
Stammnitz C, Huscher D, Bauer UMM et al (2022) Nationwide registry-based analysis of infective endocarditis risk after pulmonary valve replacement. J Am Heart Assoc 11(5):e022231. https://doi.org/10.1161/JAHA.121.022231
Konertz W, Dohmen PM, Liu J et al (2005) Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis 14(1):78–81
Christ T, Paun AC, Grubitzsch H, Holinski S, Falk V, Dushe S (2019) Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P(R) bioprosthesis used for pulmonary valve replacement. Eur J Cardiothorac Surg 55(5):885–892. https://doi.org/10.1093/ejcts/ezy377
Ruffer A, Purbojo A, Cicha I et al (2010) Early failure of xenogenous de-cellularised pulmonary valve conduits—a word of caution! Eur J Cardiothorac Surg 38(1):78–85. https://doi.org/10.1016/j.ejcts.2010.01.044
Wang Y, Chen S, Shi J, Li G, Dong N (2016) Mid- to long-term outcome comparison of the Medtronic Hancock II and bi-leaflet mechanical aortic valve replacement in patients younger than 60 years of age: a propensity-matched analysis. Interact Cardiovasc Thorac Surg 22(3):280–286. https://doi.org/10.1093/icvts/ivv347
Senage T, Paul A, Le Tourneau T et al (2022) The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration. Nat Med 28(2):283–294. https://doi.org/10.1038/s41591-022-01682-w
Cooper DK (1992) Depletion of natural antibodies in non-human primates–a step towards successful discordant xenografting in humans. Clin Transplant 6(3 part 1):178–183
Lai L, Kolber-Simonds D, Park KW et al (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295(5557):1089–1092. https://doi.org/10.1126/science.1068228
McGregor CG, Kogelberg H, Vlasin M, Byrne GW (2013) Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves. J Heart Valve Dis 22(3):383–390
Manji RA, Ekser B, Menkis AH, Cooper DK (2014) Bioprosthetic heart valves of the future. Xenotransplantation 21(1):1–10. https://doi.org/10.1111/xen.12080
Daly KA, Stewart-Akers AM, Hara H et al (2009) Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 15(12):3877–3888. https://doi.org/10.1089/ten.TEA.2009.0089
Griesemer AD, Hirakata A, Shimizu A et al (2009) Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 9(12):2669–2678. https://doi.org/10.1111/j.1600-6143.2009.02849.x
Groning M, Tahri NB, Sondergaard L, Helvind M, Ersboll MK, Orbaek AH (2019) Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves. Eur J Cardiothorac Surg 56(1):87–93. https://doi.org/10.1093/ejcts/ezy478
Van Dijck I, Budts W, Cools B et al (2015) Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 101(10):788–793. https://doi.org/10.1136/heartjnl-2014-306761
Haas NA, Bach S, Vcasna R et al (2018) The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation. Int J Cardiol 268:55–60. https://doi.org/10.1016/j.ijcard.2018.04.138
Gillespie MJ, McElhinney DB, Kreutzer J et al (2015) Transcatheter pulmonary valve replacement for right ventricular outflow tract conduit dysfunction after the ross procedure. Ann Thorac Surg 100(3):996–1002. https://doi.org/10.1016/j.athoracsur.2015.04.108. (Discussion 1002–1003)
Cabalka AK, Hellenbrand WE, Eicken A et al (2017) Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective north American and European melody valve trials. JACC Cardiovasc Interv 10(17):1746–1759. https://doi.org/10.1016/j.jcin.2017.05.022
Shinoka T, Breuer CK, Tanel RE et al (1995) Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 60(6 Suppl):S513–S516. https://doi.org/10.1016/0003-4975(95)00733-4
Hoerstrup SP, Sodian R, Daebritz S et al (2000) Functional living trileaflet heart valves grown in vitro. Circulation 102(19 Suppl 3):III44–III49. https://doi.org/10.1161/01.cir.102.suppl_3.iii-44
Emmert MY, Schmitt BA, Loerakker S et al (2018) Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan4587
Reimer J, Syedain Z, Haynie B, Lahti M, Berry J, Tranquillo R (2017) Implantation of a tissue-engineered tubular heart valve in growing lambs. Ann Biomed Eng 45(2):439–451. https://doi.org/10.1007/s10439-016-1605-7
Schmitt B, Spriestersbach H, OH-Ici D et al (2016) Percutaneous pulmonary valve replacement using completely tissue-engineered off-the-shelf heart valves: six-month in vivo functionality and matrix remodelling in sheep. EuroIntervention 12(1):62–70. https://doi.org/10.4244/EIJV12I1A12
Weber B, Dijkman PE, Scherman J et al (2013) Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials 34(30):7269–7280. https://doi.org/10.1016/j.biomaterials.2013.04.059
Schmidt D, Dijkman PE, Driessen-Mol A et al (2010) Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 56(6):510–520. https://doi.org/10.1016/j.jacc.2010.04.024
Driessen-Mol A, Emmert MY, Dijkman PE et al (2014) Transcatheter implantation of homologous “off-the-shelf” tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep. J Am Coll Cardiol 63(13):1320–1329. https://doi.org/10.1016/j.jacc.2013.09.082
Syedain Z, Reimer J, Schmidt J et al (2015) 6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep. Biomaterials 73:175–184. https://doi.org/10.1016/j.biomaterials.2015.09.016
Sharifulin R, Bogachev-Prokophiev A, Demin I et al (2018) Right ventricular outflow tract reconstruction using a polytetrafluoroethylene conduit in Ross patients. Eur J Cardiothorac Surg 54(3):427–433. https://doi.org/10.1093/ejcts/ezy128
Shinkawa T, Tang X, Gossett JM et al (2015) Valved polytetrafluoroethylene conduits for right ventricular outflow tract reconstruction. Ann Thorac Surg 100(1):129–137. https://doi.org/10.1016/j.athoracsur.2015.02.114. (Discussion 137)
Miyazaki T, Yamagishi M, Yamamoto Y et al (2019) Use of an expanded polytetrafluoroethylene valved patch with a sinus in right ventricular outflow tract reconstructiondagger. Eur J Cardiothorac Surg 56(4):671–678. https://doi.org/10.1093/ejcts/ezz089
Morales DL, Herrington C, Bacha EA et al (2020) A novel restorative pulmonary valve conduit: early outcomes of two clinical trials. Front Cardiovasc Med 7:583360. https://doi.org/10.3389/fcvm.2020.583360
Vitanova K, Cleuziou J, Horer J et al (2014) Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age? Eur J Cardiothorac Surg 46(6):961–966. https://doi.org/10.1093/ejcts/ezu080. (Discussion 966)
Hickey EJ, McCrindle BW, Blackstone EH et al (2008) Jugular venous valved conduit (Contegra) matches allograft performance in infant truncus arteriosus repair. Eur J Cardiothorac Surg 33(5):890–898. https://doi.org/10.1016/j.ejcts.2007.12.052
Niemantsverdriet MB, Ottenkamp J, Gauvreau K, Del Nido PJ, Hazenkamp MG, Jenkins KJ (2008) Determinants of right ventricular outflow tract conduit longevity: a multinational analysis. Congenit Heart Dis 3(3):176–184. https://doi.org/10.1111/j.1747-0803.2008.00190.x
Fiore AC, Ruzmetov M, Huynh D et al (2010) Comparison of bovine jugular vein with pulmonary homograft conduits in children less than 2 years of age. Eur J Cardiothorac Surg 38(3):318–325. https://doi.org/10.1016/j.ejcts.2010.01.063
Ugaki S, Rutledge J, Al Aklabi M, Ross DB, Adatia I, Rebeyka IM (2015) An increased incidence of conduit endocarditis in patients receiving bovine jugular vein grafts compared to cryopreserved homograft for right ventricular outflow reconstruction. Ann Thorac Surg 99(1):140–146. https://doi.org/10.1016/j.athoracsur.2014.08.034
Razzouk AJ, Williams WG, Cleveland DC et al (1992) Surgical connections from ventricle to pulmonary artery. Comparison of four types of valved implants. Circulation 86(5 Suppl):II154–II158
Albert JD, Bishop DA, Fullerton DA, Campbell DN, Clarke DR (1993) Conduit reconstruction of the right ventricular outflow tract. Lessons learned in a twelve-year experience. J Thorac Cardiovasc Surg 106(2):228–235 (Discussion 235–236)
Homann M, Haehnel JC, Mendler N et al (2000) Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg 17(6):624–630. https://doi.org/10.1016/s1010-7940(00)00414-0
Lange R, Weipert J, Homann M et al (2001) Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg 71(5 Suppl):S365–S367. https://doi.org/10.1016/s0003-4975(01)02552-8
Ong K, Boone R, Gao M et al (2013) Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol 111(11):1638–1643. https://doi.org/10.1016/j.amjcard.2013.01.337
Acknowledgements
This work was supported by National Institutes of Health R01s HL163085 (G.F.) and HL143008 (R.J.L. and G.F.), T32 HL007854 (E.F., A.A.), the Thoracic Surgery Foundation Resident Research Award (S.S.), The Valley Hospital Foundation ‘Marjorie C Bunnel’ charitable fund (G.F.), Andrew Sabin Family Foundation Cardiovascular Research Laboratory (G.F.), and both Erin’s Fund and the William J Rashkind Endowment of the Children’s Hospital of Philadelphia (R.J.L.).
Funding
This work received support from Thoracic Surgery Foundation, Resident Research Award, National Institutes of Health (Grant Nos. T32 HL007854, R01 HL143008, R01 HL 163085).
Author information
Authors and Affiliations
Contributions
R.J.L. and G.F. acquired funding and conceptualized the original project. S.S conceptualized the review. S.S., E.F, R.J.L. and G.F wrote the manuscript. S.S., E.F, A.A, Y.X, E.W., N.V. conducted the literature review.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Singh, S.K., Faridmoayer, E., Vitale, N. et al. Valved Conduits for Right Ventricular Outflow Tract Reconstruction: A Review of Current Technologies and Future Directions. Pediatr Cardiol (2023). https://doi.org/10.1007/s00246-023-03346-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00246-023-03346-z